
pmid: 10498493
Hair loss is a common and distressing symptom. With the approval of two drugs that promote hair growth — finasteride and minoxidil — we can now treat patients with some types of hair loss. Both drugs influence the hair-growth cycle and increase the length and diameter of existing hair, although their mechanisms of action differ. In this article, I will focus on the treatment of two common problems, androgenetic alopecia and alopecia areata, both of which involve a reversible alteration of the hair-growth cycle. The Hair-Growth Cycle Hair growth is cyclic, with phases of growth (anagen), involution (catagen), and rest . . .
Male, Alopecia Areata, Administration, Topical, Contraindications, Finasteride, Anti-Inflammatory Agents, Alopecia, Anthralin, 5-alpha Reductase Inhibitors, Minoxidil, Humans, Female, Immunotherapy, Enzyme Inhibitors, Glucocorticoids, Hair
Male, Alopecia Areata, Administration, Topical, Contraindications, Finasteride, Anti-Inflammatory Agents, Alopecia, Anthralin, 5-alpha Reductase Inhibitors, Minoxidil, Humans, Female, Immunotherapy, Enzyme Inhibitors, Glucocorticoids, Hair
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 379 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
